Suchergebnisse - "Hänel, Gerulf"

PubPharm (17)

1

Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia : a preclinical assessment

enthalten in: Leukemia | 2024

von Hänel, G. | Schönle, A. | Neumann, A. | +15

2

CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

ErratumIn: Cancer Immunol Immunother. 2023 May 8;:. - PMID 37154851

3

Correction to : CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

ErratumFor: Cancer Immunol Immunother. 2023 Jul;72(7):2499-2512. - PMID 37041225

4

Correction to: CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

5

Correction to: CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

6

CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

7

CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

8

CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

9

Harnessing T cells for immunotherapy in AML: from molecule to therapy

Erschienen: Dissertation, München, Ludwig-Maximilians-Universität, 2023

von Hänel, G. | Subklewe, M.

10

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

enthalten in: Blood | 2022

von Philipp, N. | Kazerani, M. | Nicholls, A. | +22

CommentIn: Blood. 2022 Sep 8;140(10):1056-1058. - PMID 36074532